Tag: drug companies
An Indian drugmaker, investigated by ProPublica last year, has recalled two...
FDA inspectors found serious problems at a Glenmark factory in India that manufactured the recalled drugs.
We found over 700 doctors who were paid more than a...
Back in 2013, ProPublica detailed what seemed a stunning development in the pharmaceutical industry’s drive to win the prescription pads of the...
The Big Pharma family that brought us the opioid crisis
Purdue Pharma, the drug pushers, have caused hundreds of thousands of deaths, enough fatalities to decrease overall U.S. life expectancy at birth for the last two years running.
Tom Price intervened on rule that would hurt drug profits, the...
While in Congress, HHS Secretary Tom Price acted to help kill a rule that would hurt drug company profits shortly after his broker bought him up to $90,000 worth of pharmaceutical stock.
The Real Drug Racket
Big Pharma "cornered the market on life-saving heart drugs" and guess what happened next: they jacked up the prices. Are pharmaceutical companies' business models based on legalized price gouging?
POPULAR
The $5.6 billion opening salvo: inside the staggering cost of Trump’s war on Iran
New reporting reveals that the United States burned through billions in munitions within days of launching its assault on Iran, highlighting the scale of the military campaign and its mounting financial and humanitarian toll.
How 300 billionaires poured $3 billion into the 2024 elections
A tiny fraction of donors supplied nearly one-fifth of all federal campaign spending as billionaire influence surged to unprecedented levels.
Senate Democrats demand investigation into Iran school bombing as Fetterman stands apart
Nearly the entire Democratic caucus calls for a probe into a deadly strike on a girls’ school in Minab while one senator backs the military operation.
Americans skipping meals and delaying life decisions as healthcare costs strain households nationwide
New Gallup surveys show tens of millions of Americans cutting back on food, utilities, and daily necessities to pay medical bills while healthcare affordability worsens.
The war on Iran—and Washington’s missing exit strategy
That means inflicting real costs: U.S. casualties, political backlash at home, strained relations with allies, global economic disruption and a further erosion of Washington’s standing in the world.